NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.030
-0.060 (-5.53%)
Feb 24, 2025, 11:21 AM EST - Market open
NuCana Employees
As of December 31, 2023, NuCana had 28 total employees, including 25 full-time and 3 part-time employees. The number of employees decreased by 3 or -9.68% compared to the previous year.
Employees
28
Change (1Y)
-3
Growth (1Y)
-9.68%
Revenue / Employee
n/a
Profits / Employee
-$1,244,519
Market Cap
4.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
NCNA News
- 14 days ago - Aurion Biotech Appoints Donald Munoz as Chief Financial Officer - Business Wire
- 3 months ago - NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel - GlobeNewsWire
- 5 months ago - Baillie Gifford's Strategic Acquisition of NuCana PLC Shares - GuruFocus
- 5 months ago - NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States - GlobeNewsWire
- 5 months ago - NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 - GlobeNewsWire
- 6 months ago - NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study - GlobeNewsWire
- 6 months ago - NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire